COMPETENCE TRIAL

A Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System.

We at Evaheart are glad to announce the start of the all new COMPETENCE TRIAL of the EVAHEART®2 Left Ventricular Assist Device, a true centrifugal assist device with unique breakthrough technology.

The EVAHEART®2 LVAS (EVA2) was developed to support end-stage heart failure patients as an implantable durable LVAS.

On COMPETENCE TRIAL, we aim to demonstrate EVAHEART key competences minimizing gastrointestinal bleeding, right heart failure, aortic valve insufficiency (AI), and pump thrombosis.

Learn more: https://clinicaltrials.gov/ct2/show/NCT01187368?term=evaheart&draw=1&rank=1

Please contact our professional team at Evaheart, Inc. for more information.http://www.evaheart-usa.com/